Tom Beausejour

Principal

Leland Garrahan

Vice President

Iaria, Angela

Director, Finance

Ward CFA, Jeffrey T.

Partner

7 past transactions

Qler Solutions

Series B in 2021
Qler Solutions has developed an innovative, market-leading on-demand solution to expand the delivery of psychiatric care.

Leadscope

Private Equity Round in 2020
LeadScope develops and markets a chemoinformatics application that provides access to research data. It offers toxicity databases, data management and decision support solutions, and Leadscope databases. The company also provides In silico tox, data mining, HTS analysis, lead optimization, and compound acquisition solutions. It serves national labs; pharmaceutical, biotechnology, chemical, and consumer products companies; and regulatory agencies in the United States, Canada, and Europe.

LiceGuard

Acquisition in 2012
LiceGuardĀ® is charting new territory in the treatment and prevention of lice. We are dedicated to producing safe and effective products to help families deal with their frustrating lice problems. Unlike traditional lice products that douse your children in toxic chemicals, our products are completely safe for kids - and unlike many other "natural" or "non-toxic" products, our products actually work!

OnCURE Medical

Debt Financing in 2003
Oncure was founded in 1998 and is dedicated to helping patients fight cancer through the delivery of extraordinary care. In addition, Oncure offers patients access to many of the most advanced technologies in radiation treatment. See Treatment Options for more information. Oncure does not own nor manage physician practices, rather it collaborates with its affiliated radiation oncologists to provide quality patient treatment. See Medical Advisory Board for details.

Decision Management International

Venture Round in 2001
Decision Management International, Inc. (DMI) is a leading provider of software products and consulting services for companies in FDA-regulated industries. They are internationally recognized for the development of paperless solutions for cGMP manufacturing operations that greatly reduce operational complexities and costs. These efficiencies have proven advantageous for heavily regulated companies that require detailed documentation and compliance reporting to various governmental agencies. DMI's fully integrated software product suite addresses documentation compliance procedures in the pharmaceutical, biotechnology, medical device and similar industries. DMI was established in 1993 as a consulting firm for pharmaceutical and related industries. Since its founding, DMI has developed successful complexity reduction software that leverages the Company's domain expertise. The Company, a Microsoft Certified Partner, initially created a document authoring solution and subsequently developed a technically innovative product suite that integrates document authoring, archiving, and electronic batch record solutions software for clients throughout the U.S., Canada and Europe. The Company's solid consulting track record and superior software applications have resulted in ongoing and repeat business engagements with its existing clients. In addition, DMI continues to attract an impressive roster of new clients.

VelQuest

Private Equity Round in 2000
VelQuest Corporation is the global leader in lab execution and instrument data capture software for pharmaceutical and medical device manufacturers. VelQuest solutions for lab information management, lab execution, batch record execution, and electronic data capture replace manual paper-based documentation processes, helping manufacturers to improve efficiency and reduce GMP compliance risks in quality and manufacturing operations.

TransMedics

Series A in 2000
TransMedics provides technology and clinical service solutions, service for heart and lung transplant volume, clinical outcomes, and reduce learning curves.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.